Evaluation of plasma Osteopontin as a biomarker for liver fibrosis in chronic hepatitis C patients

Manar Emad Eldin Gabr;

Abstract


Chronic HCV is one of the major causes of morbidity and mortality in the present days worldwide. Egypt has a high rate of infection (22%).
Chronic HCV infection manifests as variable degrees of hepatic inflammation and fibrosis, and as an increased risk


Other data

Title Evaluation of plasma Osteopontin as a biomarker for liver fibrosis in chronic hepatitis C patients
Other Titles قياس مستوى الاوستيوبونتين كمؤشر لتحديد درجة التليف الكبدي في مرضى الالتهاب الكبدي الفيروسي (سى)
Authors Manar Emad Eldin Gabr
Keywords Evaluation of plasma Osteopontin as a biomarker for liver fibrosis in chronic hepatitis C patients
Issue Date 2013
Description 
Chronic HCV is one of the major causes of morbidity and mortality in the present days worldwide. Egypt has a high rate of infection (22%).
Chronic HCV infection manifests as variable degrees of hepatic inflammation and fibrosis, and as an increased risk

Attached Files

File SizeFormat
115929.pdf1.06 MBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar
downloads 1 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.